基因ID | taxid | GeneDate LocusTag | Symbol Synonyms | Symbolfna Fullnamefna | dbXrefs | chromosome maplocation | description | genetype fnastatus | Otherdesignations | Featuretype |
100035156 | 10090 | 20170408 | Sphsr2 | Sphsr2 spermatocyte heat stress resistance 2 | MGI:MGI:3579343 | 11 11 40.59 cM | spermatocyte heat stress resistance 2 | unknown O | ||
100035157 | 10090 | 20211016 | Idd16.2 Idd16b | Idd16.2 insulin dependent diabetes susceptibility 16.2 | MGI:MGI:3579886 | 17 | insulin dependent diabetes susceptibility 16.2 | unknown O | insulin dependent diabetes susceptibility 16b | |
100035159 | 10090 | 20170408 | Nsila2 | Nsila2 novelty/stress induced locomotor activation 2 | MGI:MGI:3580542 | 3 3 27.73 cM | novelty/stress induced locomotor activation 2 | unknown O | ||
100035160 | 10090 | 20170408 | Nsila5 | Nsila5 novelty/stress induced locomotor activation 5 | MGI:MGI:3580545 | 6 6 7.58 cM | novelty/stress induced locomotor activation 5 | unknown O | ||
100035161 | 10090 | 20170408 | Nsila7 | Nsila7 novelty/stress induced locomotor activation 7 | MGI:MGI:3580547 | 8 8 63.1 cM | novelty/stress induced locomotor activation 7 | unknown O | ||
100035162 | 10090 | 20170408 | Crhtaq1 | Crhtaq1 Crh transcript abundance QTL 1 | MGI:MGI:3580591 | 1 | Crh transcript abundance QTL 1 | unknown O | ||
100035163 | 10090 | 20170408 | Crhtaq2 | Crhtaq2 Crh transcript abundance QTL 2 | MGI:MGI:3580592 | 12 12 60.94 cM | Crh transcript abundance QTL 2 | unknown O | ||
100035164 | 10090 | 20170408 | Avptaq2 | Avptaq2 Avp transcript abundance QTL 2 | MGI:MGI:3580595 | 12 12 13.0 cM | Avp transcript abundance QTL 2 | unknown O | ||
100035165 | 10090 | 20170408 | Crhr1taq2 | Crhr1taq2 Crhr1 transcript abundance QTL 2 | MGI:MGI:3580598 | 12 12 37.16 cM | Crhr1 transcript abundance QTL 2 | unknown O | ||
100035166 | 10090 | 20170408 | Pbmd1 | Pbmd1 peak bone mineral density 1 | MGI:MGI:3581229 | 1 1 88.97 cM | peak bone mineral density 1 | unknown O | ||
100035167 | 10090 | 20170408 | Pbmd3 | Pbmd3 peak bone mineral density 3 | MGI:MGI:3581231 | 4 4 74.75 cM | peak bone mineral density 3 | unknown O | ||
100035168 | 10090 | 20170408 | Igan3 | Igan3 IgA nephropathy 3 | MGI:MGI:3581247 | 9 9 16.12 cM | IgA nephropathy 3 | unknown O | ||
100035169 | 10090 | 20170408 | Igan4 | Igan4 IgA nephropathy 4 | MGI:MGI:3581248 | 12 12 60.56 cM | IgA nephropathy 4 | unknown O | ||
100035170 | 10090 | 20170408 | Agnm1 | Agnm1 autoimmune glomerulonephritis in MRL 1 | MGI:MGI:3582415 | 4 4 24.66 cM | autoimmune glomerulonephritis in MRL 1 | unknown O | ||
100035171 | 10090 | 20170408 | Agnm3 | Agnm3 autoimmune glomerulonephritis in MRL 3 | MGI:MGI:3582417 | 5 | autoimmune glomerulonephritis in MRL 3 | unknown O | ||
100035172 | 10090 | 20170408 | Gnf1 | Gnf1 growth and fatness 1 | MGI:MGI:3582466 | 2 | growth and fatness 1 | unknown O | ||
100035173 | 10090 | 20170408 | Emo4 | Emo4 emotionality 4 | MGI:MGI:3582653 | 1 | emotionality 4 | unknown O | ||
100035174 | 10090 | 20170408 | Reb1 | Reb1 repetitive behavior 1 | MGI:MGI:3582654 | 1 | repetitive behavior 1 | unknown O | ||
100035175 | 10090 | 20170408 | Mord2 | Mord2 modifier of retinal degeneration 2 | MGI:MGI:3583100 | 1 | modifier of retinal degeneration 2 | unknown O | ||
100035176 | 10090 | 20170408 | Cia40 | Cia40 collagen induced arthritis QTL 40 | MGI:MGI:3583353 | 11 11 32.13 cM | collagen induced arthritis QTL 40 | unknown O | collagen induced arthritis 40 | |
100035177 | 10090 | 20170408 | Bomd7 | Bomd7 bone mineral density 7 | MGI:MGI:3583579 | 11 11 54.6 cM | bone mineral density 7 | unknown O | ||
100035178 | 10090 | 20170408 | Ptnu2 | Ptnu2 proteinuria 2 | MGI:MGI:3583625 | 17 17 12.53 cM | proteinuria 2 | unknown O | ||
100035179 | 10090 | 20170408 | Ptnu4 | Ptnu4 proteinuria 4 | MGI:MGI:3583627 | 15 15 30.86 cM | proteinuria 4 | unknown O | ||
100035180 | 10090 | 20170408 | Ptnu5 | Ptnu5 proteinuria 5 | MGI:MGI:3583628 | 15 15 38.02 cM | proteinuria 5 | unknown O | ||
100035181 | 10090 | 20170408 | Salpa4 | Salpa4 serum alkaline phosphatase activity 4 | MGI:MGI:3583889 | 3 | serum alkaline phosphatase activity 4 | unknown O | ||
100035182 | 10090 | 20170408 | Ath25 | Ath25 atherosclerosis 25 | MGI:MGI:3586308 | 13 | atherosclerosis 25 | unknown O | ||
100035183 | 10090 | 20200929 | Ath26 | Ath26 atherosclerosis 26 | MGI:MGI:3586309 | 17 | atherosclerosis 26 | unknown O | ||
100035184 | 10090 | 20170408 | Ath28 | Ath28 atherosclerosis 28 | MGI:MGI:3586311 | 2 | atherosclerosis 28 | unknown O | ||
100035185 | 10090 | 20170408 | Bw21 | Bw21 body weight QTL 21 | MGI:MGI:3586314 | 19 | body weight QTL 21 | unknown O | ||
100035186 | 10090 | 20170408 | Bw22 | Bw22 body weight QTL 22 | MGI:MGI:3586315 | 2 | body weight QTL 22 | unknown O | ||
100035187 | 10090 | 20170408 | Htas5 | Htas5 hypothermia due to alcohol sensitivity 5 | MGI:MGI:3587072 | 13 | hypothermia due to alcohol sensitivity 5 | unknown O | ||
100035188 | 10090 | 20170408 | Htas9 | Htas9 hypothermia due to alcohol sensitivity 9 | MGI:MGI:3587076 | 2 | hypothermia due to alcohol sensitivity 9 | unknown O | ||
100035189 | 10090 | 20170408 | Cplaq11 | Cplaq11 circadian period of locomotor activity 11 | MGI:MGI:3588346 | 13 | circadian period of locomotor activity 11 | unknown O | ||
100035190 | 10090 | 20211016 | Artmd1 Amd1 | Artmd1 arthropathy in MRL and DBA/1 mice 1 | MGI:MGI:3588383 | 10 10 37.15 cM | arthropathy in MRL and DBA/1 mice 1 | unknown O | ||
100035191 | 10090 | 20170408 | Ses8 | Ses8 salmonella enteritidis susceptibility 8 | MGI:MGI:3588676 | 4 4 10.61 cM | salmonella enteritidis susceptibility 8 | unknown O | ||
100035192 | 10090 | 20170408 | Ses10 | Ses10 salmonella enteritidis susceptibility 10 | MGI:MGI:3588678 | 13 13 52.9 cM | salmonella enteritidis susceptibility 10 | unknown O | ||
100035193 | 10090 | 20170408 | Zit1 | Zit1 zinc induced tolerance 1 | MGI:MGI:3588721 | 1 1 84.32 cM | zinc induced tolerance 1 | unknown O | ||
100035194 | 10090 | 20170408 | Pbwg15 | Pbwg15 postnatal body weight growth 15 | MGI:MGI:3589175 | 9 | postnatal body weight growth 15 | unknown O | ||
100035195 | 10090 | 20170408 | Pbwg18 | Pbwg18 postnatal body weight growth 18 | MGI:MGI:3589178 | 14 | postnatal body weight growth 18 | unknown O | ||
100035196 | 10090 | 20170408 | Pbwg20 | Pbwg20 postnatal body weight growth 20 | MGI:MGI:3589180 | 19 | postnatal body weight growth 20 | unknown O | ||
100035197 | 10090 | 20170408 | Gsi1 | Gsi1 glomerulsclerosis index 1 | MGI:MGI:3589615 | 8 8 32.3 cM | glomerulsclerosis index 1 | unknown O | ||
100035198 | 10090 | 20170408 | Gsi2 | Gsi2 glomerulsclerosis index 2 | MGI:MGI:3589616 | 10 10 66.65 cM | glomerulsclerosis index 2 | unknown O | ||
100035199 | 10090 | 20170408 | Vacq1 | Vacq1 voluntary alcohol consumption QTL 1 | MGI:MGI:3590246 | 2 2 103.43 cM | voluntary alcohol consumption QTL 1 | unknown O | ||
100035200 | 10090 | 20170408 | Vacq3 | Vacq3 voluntary alcohol consumption QTL 3 | MGI:MGI:3590248 | 2 2 6.25 cM | voluntary alcohol consumption QTL 3 | unknown O | ||
100035201 | 10090 | 20170408 | Vacq6 | Vacq6 voluntary alcohol consumption QTL 6 | MGI:MGI:3590251 | 10 10 3.66 cM | voluntary alcohol consumption QTL 6 | unknown O | ||
100035202 | 10090 | 20170408 | Exq4 | Exq4 exploratory and excitability QTL 4 | MGI:MGI:3590279 | 19 19 34.08 cM | exploratory and excitability QTL 4 | unknown O | ||
100035203 | 10090 | 20170408 | Marq1 | Marq1 methamphetamine response QTL 1 | MGI:MGI:3590510 | 5 5 63.84 cM | methamphetamine response QTL 1 | unknown O | ||
100035204 | 10090 | 20170408 | Marq2 | Marq2 methamphetamine response QTL 2 | MGI:MGI:3590511 | 9 9 71.49 cM | methamphetamine response QTL 2 | unknown O | ||
100035205 | 10090 | 20170408 | Marq5 | Marq5 methamphetamine response QTL 5 | MGI:MGI:3590514 | 15 15 39.98 cM | methamphetamine response QTL 5 | unknown O | ||
100035206 | 10090 | 20171031 | Mpdk2 | Mpdk2 modifier of polycystic kidney disease 2 | MGI:MGI:3603221 | 4 | modifier of polycystic kidney disease 2 | unknown O |
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025 |